Helen Matthews

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 17 papers. Top paper: “GDNF and Parkinson’s Disease: Where Next? A Summary from a Recent Workshop”.

GDNF and Parkinson’s Disease: Where Next? A Summary from a Recent Workshop

Journal of Parkinson's Disease(2020)10.3233/jpd-202004

N/A

3.5DataRank · unranked

135 citations

Anders Björklund, Don M. Gash, Alan Whone, Amber Van Laar, Jeffrey H. Kordower +26 more

Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinson's disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial

The Lancet(2025)10.1016/s0140-6736(24)02808-3

N/A

2.3DataRank · unranked

131 citations

Christine Girges, Grace Auld, Rachel McComish, Alexa King, Simon S. Skene +32 more

A Double-Blind, Placebo-Controlled, Crossover Study of Magnesium Supplementation in Patients with XMEN Disease

Journal of Clinical Immunology(2021)10.1007/s10875-021-01137-w

N/A

1.8DataRank · unranked

19 citations

Susan Price, Juan Zou, Sally Hunsberger, Alessandra Brofferio, Helen Matthews +7 more

Evaluating the efficacy and safety of pozelimab in patients with CD55 deficiency with hyperactivation of complement, angiopathic thrombosis, and protein-losing enteropathy disease: an open-label phase 2 and 3 study

The Lancet(2024)10.1016/s0140-6736(23)02358-9

N/A

0.995DataRank · unranked

28 citations

Voranush Chongsrisawat, Asena Pınar Sefer, Burcu Kolukısa, Jessica J. Jalbert, Karoline A. Meagher +35 more

Human immunodeficiency reveals GIMAP5 as lymphocyte-specific regulator of senescence

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.02.22.432146

N/A

0DataRank · unranked

6 citations

Michael Leney-Greene, Matthew Lynberg, Xijin Xu, Lixin Zheng, Yu Zhang +19 more

Immunopathological signatures in multisystem inflammatory syndrome in children and pediatric COVID-19

Nature Medicine(2022)10.1038/s41591-022-01724-3

N/A

0DataRank · unranked

254 citations

Riccardo Castagnoli, Svetlana Vakkilainen, Can Liu, Ottavia M. Delmonte, Cihan Oguz +85 more

Mucus sialylation determines intestinal host-commensal homeostasis

Cell(2022)10.1016/j.cell.2022.02.013

N/A

0DataRank · unranked

237 citations

Girak Kim, Samantha Shafer, Zuojia Chen, Satoshi Kubo, Yanlong Ji +45 more

Abnormal antibodies to self-carbohydrates in SARS-CoV-2-infected patients

PNAS Nexus(2022)10.1093/pnasnexus/pgac062

N/A

0DataRank · unranked

22 citations

Luisa Imberti, Virginia Quaresima, Chiara Fiorini, Jason Barnett, Samuel D. Chauvin +18 more

Serological responses to human virome define clinical outcomes of Italian patients infected with SARS-CoV-2

International Journal of Biological Sciences(2022)10.7150/ijbs.78002

N/A

0DataRank · unranked

7 citations

Julián Candia, Lichun Ma, Yongmei Zhao, Luisa Imberti, Alessandra Sottini +18 more

Deep immune profiling uncovers novel associations with clinical phenotypes of multisystem inflammatory syndrome in children (MIS-C)

Annals of the Rheumatic Diseases(2022)10.1136/ard-2022-223269

N/A

0DataRank · unranked

4 citations

Moses M. Kitakule, Aran Son, McKella Sylvester, Keith Sacco, Ottavia M. Delmonte +18 more

Deep immune profiling uncovers novel associations with clinical phenotypes of Multisystem Inflammatory Syndrome in Children (MIS-C)

medRxiv(2022)10.1101/2022.08.31.22279265

N/A

0DataRank · unranked

0 citations

Moses M. Kitakule, Aran Son, McKella Sylvester, Keith Sacco, Ottavia M. Delmonte +18 more

Perturbations of the T-cell receptor repertoire in response to SARS-CoV-2 in immunocompetent and immunocompromised individuals

Journal of Allergy and Clinical Immunology(2023)10.1016/j.jaci.2023.12.011

N/A

0DataRank · unranked

17 citations

Cihan Oguz, Kerry Dobbs, Katherine Myint‐Hpu, Boaz Palterer, Michael S. Abers +51 more

Germline mutations in a G protein identify signaling cross-talk in T cells

Science(2024)10.1126/science.add8947

N/A

0DataRank · unranked

24 citations

Huie Jing, Ian T. Lamborn, M. Kober, Alexey Koval, Yamina A. Berchiche +95 more

GIMAP5 deficiency reveals a mammalian ceramide-driven longevity assurance pathway

Nature Immunology(2024)10.1038/s41590-023-01691-y

N/A

0DataRank · unranked

13 citations

Michael Leney-Greene, Matthew Lynberg, Justin Q. Gabrielski, Xijin Xu, Benjamin Schwarz +69 more

Congenital iRHOM2 deficiency causes ADAM17 dysfunction and environmentally directed immunodysregulatory disease

Nature Immunology(2021)10.1038/s41590-021-01093-y

N/A

0DataRank · unranked

21 citations

Jill M. Fritz, Hayley M. Raquer-McKay, Rhea Kataria, Ivan Vujkovic-Cvijin, Ahmad Al‐Shaibi +29 more

Homozygous IL37 mutation associated with infantile inflammatory bowel disease

Proceedings of the National Academy of Sciences(2021)10.1073/pnas.2009217118

N/A

0DataRank · unranked

25 citations

Yu Zhang, Tingyan He, Colin L. Sweeney, Safa Barış, Elif Karakoç-Aydıner +10 more

Seeking progress in disease modification in Parkinson disease

Parkinsonism & Related Disorders(2021)10.1016/j.parkreldis.2021.09.006

N/A

0DataRank · unranked

15 citations

Jesse M. Cedarbaum, Ted M. Dawson, E. Ray Dorsey, Carlos Alberto Faraco, Howard J. Federoff +18 more